StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the stock.
Milestone Scientific Stock Up 0.5 %
MLSS opened at $0.68 on Thursday. The firm has a market cap of $52.77 million, a PE ratio of -6.83 and a beta of 0.90. The business has a fifty day simple moving average of $0.69 and a 200-day simple moving average of $0.66. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.35.
Milestone Scientific (NYSE:MLSS – Get Free Report) last released its earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%. The business had revenue of $2.25 million during the quarter.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
- Five stocks we like better than Milestone Scientific
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
